Correction to: Eye https://doi.org/10.1038/s41433-021-01807-4, published online 05 January 2022
In the first published version of this article, the corresponding author was listed incorrectly. The corresponding author is only Giulia De Rossi, e-mail: giulia.derossi@ucl.ac.uk
The original article has been corrected
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1038/s41433-021-01807-4.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
De Rossi, G., Da Vitoria Lobo, M.E., Greenwood, J. et al. Correction: LRG1 as a novel therapeutic target in eye disease. Eye 37, 1517 (2023). https://doi.org/10.1038/s41433-022-01988-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-022-01988-6
